Erden, IsmailOzhan, HakanOrdu, Serkan2024-09-252024-09-2520100022-9032https://hdl.handle.net/20.500.12491/13150Acute stent thrombosis (AST) is occasionally observed during percutaneous coronary intervention in patients with acute coronary syndrome (ACS). It may jeopardize hemodynamic status. Currently, there is no adequate solution for this problem. We report our experience with an ACS patient who developed AST associated with cardiogenic shock after percutaneous coronary stent deployment. Intracoronary administration of tirofiban immediately restored the coronary flow of the target vessel, and the disastrous condition was reversed. Our experience suggests that intracoronary administration of tirofiban can be considered as an option in cases of AST during percutaneous coronary intervention.eninfo:eu-repo/semantics/closedAccessacute stent thrombosisintracoronary tirofibanEditorial68448548820425719WOS:000277384900017Q4